Unlock Premium Data: Up to 50% Off InvestingProCLAIM SALE

Australia struggles to sate China's appetite for foreign baby formula

Published 11/11/2015, 07:28 pm
Updated 11/11/2015, 07:30 pm
© Reuters.  Australia struggles to sate China's appetite for foreign baby formula
WES
-
WOW
-
BAL
-
A2M
-

By Byron Kaye and Colin Packham

SYDNEY, Nov 11 (Reuters) - Supplies of baby formula are drying up in Australia as savvy Chinese tourists snatch tins of the "white gold" off supermarket shelves to resell them for a profit at home, where a poisoning scandal has left consumers wary of domestic brands.

As Australian lawmakers pass a A$100-billion ($70 billion) free trade pact with China, the shortage suggests food manufacturers in a country of 23.6 million people will struggle to meet the demand from a country of 1.4 billion.

"There has been a lot of talk about a 'mining boom to dining boom' but the reality is that on sheer volume Australia is not able to supply them with all their caloric needs," said Phin Ziebell, an agribusiness economist at National Australia Bank.

"We simply can't do it."

China's appetite has forced the top two supermarket chains, Woolworths Ltd WOW.AX and Coles, owned by Wesfarmers Ltd WES.AX , to ration sales of baby formula, or "white gold", as Australian media have dubbed it, while manufacturers boost output to meet demand.

After Hong Kong and Britain adopted enforced rationing in 2013, Australian sales of baby formula have soared, as Chinese visitors exploit the safety concerns over domestic products to offload Australian purchases at mark-ups as high as 500 percent.

Shoppers from China, which eased family planning curbs last month to allow couples to have two children, also benefit from a weak Australian dollar, now hovering near one-month lows.

Although legal in Australia for exports of less than 10 kg (22 lb), the trend set off a backlash this week, when a mother posted a picture on social media of someone buying what appeared to be one retailer's entire stock of about 10 crates of formula.

Shares of formula maker Bellamy's Australia Ltd BAL.AX have risen nearly 10-fold in a year, taking its market value to almost A$1 billion, from A$97 million at listing in 2014.

Bellamy's charges A$38 in China for a tin sold at A$25 in Australia, the company says on its website.

Shares of rival A2 Milk A2M.AX have risen 68 percent since they listed in March.

"There's not product shortage as much as there is heightened demand by Chinese tourists," said Peter Nathan, A2's chief executive for Australia.

"We're doing everything we can to increase supply and it's up to retailers to manage product appropriately."

In a statement, Assistant Trade Minister Richard Colbeck said he had spoken to supermarket and pharmacy representatives about ways of ensuring access to reliable supplies of infant formula for Australian parents, but did not elaborate.

($1=1.4164 Australian dollars)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.